WASHINGTON - Regulators said on Friday they were reviewing the safety of Allergan Inc's Botox and a competing product after reports of deaths and serious reactions in some patients.
The Food and Drug Administration said the most serious cases included hospitalizations and deaths and occurred mostly in children. Full Story - Discount Magazine Subscriptions - Discount Cigarettes & Tobacco - Nutty News Marketplace - Catherines Plus Sizes
The Food and Drug Administration said the most serious cases included hospitalizations and deaths and occurred mostly in children. Full Story - Discount Magazine Subscriptions - Discount Cigarettes & Tobacco - Nutty News Marketplace - Catherines Plus Sizes